Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
ABOUT THIS PAGE
99
PharmaCompass offers a list of Nimustine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nimustine manufacturer or Nimustine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nimustine manufacturer or Nimustine supplier.
PharmaCompass also assists you with knowing the Nimustine API Price utilized in the formulation of products. Nimustine API Price is not always fixed or binding as the Nimustine Price is obtained through a variety of data sources. The Nimustine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nimustine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nimustine, including repackagers and relabelers. The FDA regulates Nimustine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nimustine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nimustine supplier is an individual or a company that provides Nimustine active pharmaceutical ingredient (API) or Nimustine finished formulations upon request. The Nimustine suppliers may include Nimustine API manufacturers, exporters, distributors and traders.
click here to find a list of Nimustine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nimustine DMF (Drug Master File) is a document detailing the whole manufacturing process of Nimustine active pharmaceutical ingredient (API) in detail. Different forms of Nimustine DMFs exist exist since differing nations have different regulations, such as Nimustine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nimustine DMF submitted to regulatory agencies in the US is known as a USDMF. Nimustine USDMF includes data on Nimustine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nimustine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nimustine suppliers with USDMF on PharmaCompass.
Nimustine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nimustine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nimustine GMP manufacturer or Nimustine GMP API supplier for your needs.
A Nimustine CoA (Certificate of Analysis) is a formal document that attests to Nimustine's compliance with Nimustine specifications and serves as a tool for batch-level quality control.
Nimustine CoA mostly includes findings from lab analyses of a specific batch. For each Nimustine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nimustine may be tested according to a variety of international standards, such as European Pharmacopoeia (Nimustine EP), Nimustine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nimustine USP).
